As of close of business last night, Zai Lab Limited ADR’s stock clocked out at $15.45, down -2.83% from its previous closing price of $15.90. In other words, the price has decreased by -$0.45 from its previous closing price. On the day, 540763 shares were traded.
Ratios:
To gain a deeper understanding of ZLAB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.41 and its Current Ratio is at 4.63. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 14, 2023, initiated with a Overweight rating and assigned the stock a target price of $47.50.
On August 10, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $70.
On January 21, 2022, Macquarie started tracking the stock assigning a Outperform rating and target price of $64.Macquarie initiated its Outperform rating on January 21, 2022, with a $64 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 02 ’24 when Du Ying sold 5,787 shares for $16.15 per share. The transaction valued at 93,466 led to the insider holds 1,107,972 shares of the business.
Reinhart Harald sold 1,773 shares of ZLAB for $28,636 on Apr 02 ’24. The insider now owns 48,635 shares after completing the transaction at $16.15 per share. On Apr 02 ’24, another insider, Edmondson Frazor Titus III, who serves as the Chief Legal Officer of the company, sold 885 shares for $16.15 each. As a result, the insider received 14,294 and left with 22,621 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 1.58B and an Enterprise Value of 787.65M. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.72 while its Price-to-Book (P/B) ratio in mrq is 1.89. Its current Enterprise Value per Revenue stands at 2.95 whereas that against EBITDA is -2.16.
Stock Price History:
Over the past 52 weeks, ZLAB has reached a high of $40.42, while it has fallen to a 52-week low of $15.53. The 50-Day Moving Average of the stock is 19.63, while the 200-Day Moving Average is calculated to be 24.70.
Shares Statistics:
It appears that ZLAB traded 673.82K shares on average per day over the past three months and 733.23k shares per day over the past ten days. A total of 98.72M shares are outstanding, with a floating share count of 98.31M. Insiders hold about 0.41% of the company’s shares, while institutions hold 42.47% stake in the company. Shares short for ZLAB as of Mar 15, 2024 were 3.66M with a Short Ratio of 5.44, compared to 4.69M on Feb 15, 2024.
Earnings Estimates
As of right now, 5 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.9 for the current quarter, with a high estimate of -$0.75 and a low estimate of -$1.04, while EPS last year was -$0.51. The consensus estimate for the next quarter is -$0.85, with high estimates of -$0.75 and low estimates of -$0.91.
Analysts are recommending an EPS of between $5.6 and -$3.53 for the fiscal current year, implying an average EPS of -$2.24. EPS for the following year is -$1.26, with 8 analysts recommending between $3.4 and -$2.63.
Revenue Estimates
In the current quarter, 5 analysts expect revenue to total $74.19M. It ranges from a high estimate of $77.66M to a low estimate of $67.9M. As of the current estimate, Zai Lab Limited ADR’s year-ago sales were $64.97M, an estimated increase of 14.20% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $86.17M, an increase of 22.00% over than the figure of $14.20% in the same quarter last year. There is a high estimate of $87.2M for the next quarter, whereas the lowest estimate is $84.59M.
A total of 9 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $398M, while the lowest revenue estimate was $365.7M, resulting in an average revenue estimate of $381.69M. In the same quarter a year ago, actual revenue was $266.72M, up 43.10% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $590.86M in the next fiscal year. The high estimate is $647.33M and the low estimate is $533.5M. The average revenue growth estimate for next year is up 54.80% from the average revenue estimate for this year.
